$65.9 Million
OrthoPediatrics Corp.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$86.2 Million
Neoleukin Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
$74.2 Million
Aptose Biosciences Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$110.5 Million
Revance Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$53.6 Million
OptiNose AS
Confidentially Marketed Follow-On Offering
Active Bookrunner
$115.0 Million
Arvinas
Confidentially Marketed Follow-On Offering
Active Bookrunner
$143.8 Million
Ardelyx Inc
Confidentially Marketed Follow-On Offering
Active Bookrunner
$75.2 Million
MeiraGTx Holdings plc
Confidentially Marketed Follow-On Offering
Active Bookrunner
$55.0 Million
Chiasma, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$126.5 Million
Cara Therapeutics Inc.
Confidentially Marketed Follow-On Offering
Passive Bookrunner
Subscribe to United States

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.